z-logo
open-access-imgOpen Access
ANALISIS KADAR C-REACTIVE PROTEIN PADA PASIEN LANJUT USIA DENGAN KOMORBID YANG TERKONFIRMASI POSITIF COVID-19 DI RSUD PASAR REBO
Author(s) -
Enny Khotimah,
Amalia Amalia
Publication year - 2021
Publication title -
jurnal analis laboratorium medik
Language(s) - English
Resource type - Journals
ISSN - 2527-712X
DOI - 10.51544/jalm.v6i2.2397
Subject(s) - medicine , covid-19 , c reactive protein , elderly people , cross sectional study , univariate analysis , immune system , disease , comorbidity , gastroenterology , immunology , multivariate analysis , inflammation , pathology , gerontology , infectious disease (medical specialty)
Coronavirus Disease 2019 (COVID-19) is a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Severe cases of SARS-CoV-2 infection are characterized by a systemic inflammatory response in acute respiration. The inflammatory response can be checked by laboratory tests with C-Reactive Protein. The purpose of this study was to determine CRP levels in elderly patients with comorbidities who were confirmed positive for Covid-19. This type of research is descriptive quantitative with a cross-sectional design using accidental sampling technique obtained a sample of 56 patients. This research was conducted at Pasar Rebo Hospital. Based on the univariate statistical test, the frequency distribution of males was 29 people (51.8%) while women were 27 people (48.2%), the elderly group with the highest group was in the elderly group with an age range of 65-69 years as many as 22 people (39.3%), elderly patients with comorbid Hypertension dominate as many as 18 people (32.1%). The results of laboratory examinations showed an increase in levels of C-Reactive Protein which varied, this was accompanied by the condition of patients who had clinical comorbidities. Covid-19 in the elderly also worsens the symptoms and course of Covid-19, due to decreased immune function, the immune system of organs and the many clinical comorbidities that occur.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here